Standout Papers

Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> Variants 2023 2026 202487
  1. Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants (2023)
    Ogo Egbuna, Brandon Zimmerman et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 54 standout
Sub-graph 1 of 20

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
A widely distributed gene cluster compensates for uricase loss in hominids
2023 Standout
2 intermediate papers

Works of Michael S. Lipkowitz being referenced

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression
2018
Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling
2016

Author Peers

Author Last Decade Papers Cites
Michael S. Lipkowitz 1448 624 672 84 2.7k
Julie Lin 1952 556 696 65 4.2k
Giuseppe Coppolino 1774 567 509 134 3.3k
Susanne B. Nicholas 870 776 490 85 2.6k
Wen‐Chih Chiang 1506 992 357 72 3.2k
Gavin J. Becker 1568 617 579 140 4.0k
G Mecca 1364 347 479 59 3.3k
Stephan R. Orth 2020 562 1180 57 4.1k
Francis Verbeke 1687 328 953 67 3.2k
Denise Maria Avancini Costa Malheiros 990 751 329 109 3.3k
John P. Middleton 1275 821 740 76 3.1k

All Works

Loading papers...

Rankless by CCL
2026